52 research outputs found
Burocracia
Puede parecer paradójico a algunos de nuestros lectores que mientras profesamos una gran hostilidad a la burocracia, o a la interferencia de un gobierno centralizado en asuntos familiares y de la vida privada de los individuos, al mismo tiempo debamos salir en defensa de una encuesta gubernamental realizada sobre nuestra educación por una Comisión especial, la cual probablemente resultará en una mayor interferencia del gobierno.Esto es más valedero en el caso de este tema, si consideramos que podríamos arreglárnosla del todo en la educación sin la intervención del Gobierno, algo que deberíamos preferir absolutamente; pero resulta que todas nuestras mentes más sensatas ya han llegado a la conclusión de que esto es imposible, tanto por nuestra pobreza y debilidad personales, como por el poder y la voluntad del Gobierno. El problema, por lo tanto, es hacer lo mejor que esté a nuestro alcance, y nuestra recomendación de cooperar con la Comisión se basa totalmente en esta consideración
Leader identity on the fly: Intra-personal leader identity dynamics in response to strong events
Recent theorizing challenges the notion that leadership, and especially leader identities, are static. Yet, we know little about the dynamics that characterize how leader identities change within individuals across short periods of time. The current work integrates theorizing on temporal dynamics in leadership research with event systems theory to describe and predict day-to-day shifts (i.e., unidirectional, sudden changes) and dynamic ebb and flow patterns (i.e., multidirectional, potentially nonlinear changes over multiple days) of individuals’ leader identities. Specifically, we argue that the experience of strong (i.e., novel, disruptive, extraordinary) daily events facilitates positive leader identity shifts, and that over time the resulting identity ebb and flows are more pronounced in unfamiliar compared to familiar contexts. We collected experience sampling data from 69 young adults at a university in the United Kingdom across seven-day periods at three different time points during the academic year (1,159 data points). Using Dynamical Systems Modeling, we analyze the velocity (i.e., rate of change) and the acceleration (i.e., change in velocity) parameters of individuals’ leader identity dynamics. We find that (a) on a daily level, strong events prompt positive shifts in leader identity, and that (b) over time, chains of stronger and weaker events provoke similar patterns of leader identity ebb and flows. However, these relationships are not stronger in unfamiliar compared to familiar contexts. Our research informs the theoretical understanding of events and short-term leader identity dynamics. We discuss implications for theory and research, in particular how events can trigger leader identity formation
Recommended from our members
Effect of rehabilitation worker input on visual function outcomes in individuals with low vision: study protocol for a randomised controlled trial
BACKGROUND: Visual Rehabilitation Officers help people with a visual impairment maintain their independence. This intervention adopts a flexible, goal-centred approach, which may include training in mobility, use of optical and non-optical aids, and performance of activities of daily living. Although Visual Rehabilitation Officers are an integral part of the low vision service in the United Kingdom, evidence that they are effective is lacking. The purpose of this exploratory trial is to estimate the impact of a Visual Rehabilitation Officer on self-reported visual function, psychosocial and quality-of-life outcomes in individuals with low vision.
METHODS/DESIGN: In this exploratory, assessor-masked, parallel group, randomised controlled trial, participants will be allocated either to receive home visits from a Visual Rehabilitation Officer (n = 30) or to a waiting list control group (n = 30) in a 1:1 ratio. Adult volunteers with a visual impairment, who have been identified as needing rehabilitation officer input by a social worker, will take part. Those with an urgent need for a Visual Rehabilitation Officer or who have a cognitive impairment will be excluded. The primary outcome measure will be self-reported visual function (48-item Veterans Affairs Low Vision Visual Functioning Questionnaire). Secondary outcome measures will include psychological and quality-of-life metrics: the Patient Health Questionnaire (PHQ-9), the Warwick-Edinburgh Mental Well-being Scale (WEMWBS), the Adjustment to Age-related Visual Loss Scale (AVL-12), the Standardised Health-related Quality of Life Questionnaire (EQ-5D) and the UCLA Loneliness Scale. The interviewer collecting the outcomes will be masked to the group allocations. The analysis will be undertaken on a complete case and intention-to-treat basis. Analysis of covariance (ANCOVA) will be applied to follow-up questionnaire scores, with the baseline score as a covariate.
DISCUSSION: This trial is expected to provide robust effect size estimates of the intervention effect. The data will be used to design a large-scale randomised controlled trial to evaluate fully the Visual Rehabilitation Officer intervention. A rigorous evaluation of Rehabilitation Officer input is vital to direct a future low vision rehabilitation strategy and to help direct government resources.
TRIAL REGISTRATION: The trial was registered with ( ISRCTN44807874 ) on 9 March 2015
Margarita de Sossa, Sixteenth-Century Puebla de los Ángeles, New Spain (Mexico)
Margarita de Sossa’s freedom journey was defiant and entrepreneurial. In her early twenties, still enslaved in Portugal, she took possession of her body; after refusing to endure her owner’s sexual demands, he sold her, and she was transported to Mexico. There, she purchased her freedom with money earned as a healer and then conducted an enviable business as an innkeeper. Sossa’s biography provides striking insights into how she conceptualized freedom in terms that included – but was not limited to – legal manumission. Her transatlantic biography offers a rare insight into the life of a free black woman (and former slave) in late sixteenth-century Puebla, who sought to establish various degrees of freedom for herself. Whether she was refusing to acquiesce to an abusive owner, embracing entrepreneurship, marrying, purchasing her own slave property, or later using the courts to petition for divorce. Sossa continued to advocate on her own behalf. Her biography shows that obtaining legal manumission was not always equivalent to independence and autonomy, particularly if married to an abusive husband, or if financial successes inspired the envy of neighbors
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome
- …